Vaccine sceptic Novak Djokovic holds major stakes in a firm developing Covid drug, says CEO

Updated : Jan 20, 2022 09:37
|
Editorji News Desk

Covid vaccine sceptic Novak Djokovic who bore the brunt of his denial after he was sent back from Australia holds major stakes in a firm developing Covid-19 drugs, confirmed the Danish Company's CEO. 

Also Read Premier League: Marcus Rashford ends goal drought as Man United beat Brentford 3-1

He is one of the founders of my company, which we founded in June 2020, the CEO of QuantBioRes Ivan Loncarevic said on Wednesday. As per the information available publicly, the 20-time Grand Slam Champion who missed his chance at the ongoing Australian Open due to the vaccination row holds 80% stakes in the company along with his wife Jelena. 

Loncarevic informed that his company is working for drugs against different viruses and are using Covid as a showcase. 

The 9+time Australian Open Champion had a dramatic start to the year after the Australian government denied his entry in Melbourne due to his vaccination status. The World no. 1 was sent back just before the start of the first Grand Slam of the year.  

AUS OPENNovak DjokovicGrand slam

Recommended For You

editorji | Sports

Iran 'negotiating' with FIFA over moving World Cup games to Mexico: embassy

editorji | Sports

IPL first phase schedule announced amid travel concerns caused by war in West Asia

editorji | Sports

Rinku Singh’s father Khanchand Singh passes away after battling stage 4 liver cancer

editorji | Sports

T20 World Cup: Abhishek, Hardik help India pulverise Zimbabwe by 72 runs; stay in semis race

editorji | Sports

T20 World Cup: Clinical South Africa hammer West Indies by nine wickets, tighten grip on semifinal spot